Aquilo Capital Management
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- USA
- California
- Massachusetts
- Connecticut
- New Jersey
- Belgium
- East Flanders
- Denmark
- Copenhagen
Investment stages
- Seed
- Series A
Industries
- Health Tech
- Biotechnology
- AI
- Data Science
About
Aquilo Capital Management is a biotech hedge fund that invests in drug development companies leveraging scientific breakthroughs to revolutionize medicine, using a disciplined, value‑oriented process and deep sector expertise.
Aquilo Capital Management is a biotech hedge fund that invests in drug development companies leveraging scientific breakthroughs to revolutionize medicine, using a disciplined, value‑oriented process and deep sector expertise.
Investment Thesis
Aquilo Capital invests in drug development companies that harness the poTheyr of cuttingedge science to address urgent medical needs.
Manager's Experience
Focused on technology and consumer sectors, the fund manager has successfully led over 50 deals across North America and Europe. Known for a growth-oriented investment style, they emphasize early-stage opportunities with a track record of substantial exits. Backed by a top-tier network, their strategy combines rigorous analysis with an operator-first approach, resulting in high returns and impactful scaling. Specializes in identifying disruptive trends, positioning their portfolio for long-term success in competitive markets.
Aquilo Capital Management Contacts Information
Primary contact
Team
Patrick Rivers